/Lists

Longevity Series B Investors & VC Firms

76 firms in this list, with a median first check of $540K. 22 of them lead rounds. Generated from verified public data and updated continuously.

The Column Group
San FranciscoPre-Seed–Late Stage$30M
38 people
aMoon
Ra'ananaSeed–Late Stage
33 people
Northern Gritstone
ManchesterSeed–Growth
41 people
Type One Ventures
Los AngelesPre-Seed–Late Stage$100K – $5M
28 people
JAZZ Venture Partners
San FranciscoSeed–Growth$100K – $20M
16 people
Two Bear Capital
WhitefishPre-Seed–Series B$3M – $10M
34 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Growth
29 people
Lumira Ventures
TorontoSeed–Growth$1M – $10M
17 people
iSelect Fund
St. LouisSeed–Series B$250K – $2M
10 people
King River Capital
SydneySeed–Series B
23 people
Lauder Partners
Los AltosSeed–Growth
1 person
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
LYFE Capital
Menlo ParkSeed–Late Stage
22 people
Pontifax Venture Capital
HerzeliyaSeed–Late Stage
7 people
Northstar Ventures
Newcastle upon TynePre-Seed–Late Stage$38.1K – $1.3M
17 people
Merck Global Health Innovation Fund
RahwaySeed–Growth$10M
10 people
Hadean Ventures
OsloSeed–Growth
21 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
DCVC Bio
Palo AltoSeed–Growth
14 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
Sciety
StockholmSeed–Growth
21 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
V-Bio Ventures
GhentSeed–Series B$270K – $2.2M
13 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.